| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CDK9 ZNF717 KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF275 ZNF236 PRDM5 ZNF865 ZNF840P KLF16 ZNF668 ZFHX4 EGR4 ZNF335 GLIS2 ZNF667 ZNF778 ZNF770 KLF18 ZFP92 ZNF319 | 3.17e-08 | 1244 | 107 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CDK9 ZNF717 KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF275 ZNF236 PRDM5 ZNF865 ZNF840P KLF16 ZNF668 ZFHX4 EGR4 ZNF335 GLIS2 ZNF667 ZNF778 ZNF770 KLF18 ZFP92 ZNF319 | 4.76e-08 | 1271 | 107 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CDK9 ZNF717 KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF275 ZNF236 PRDM5 ZNF865 ZNF840P KLF16 ZNF668 ZFHX4 EGR4 ZNF335 GLIS2 ZNF667 NFX1 ZNF778 ZNF770 KLF18 ZFP92 ZNF319 | 1.54e-07 | 1459 | 107 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF717 KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF275 ZNF236 PRDM5 ZNF840P KLF16 ZNF668 ZFHX4 EGR4 ZNF451 GLIS2 NFX1 ZNF778 ZNF770 KLF18 ZFP92 ZNF319 | 4.75e-06 | 1412 | 107 | 22 | GO:0000981 |
| Domain | zf-C2H2 | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 4.14e-14 | 693 | 103 | 25 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 5.05e-13 | 775 | 103 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 5.34e-13 | 777 | 103 | 25 | PS00028 |
| Domain | Znf_C2H2 | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 1.17e-12 | 805 | 103 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 1.27e-12 | 808 | 103 | 25 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 2.93e-12 | 694 | 103 | 23 | IPR013087 |
| Domain | Znf_C2H2-like | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 ZNF687 | 6.71e-12 | 796 | 103 | 24 | IPR015880 |
| Domain | - | KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 ZFHX4 EGR4 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 | 1.46e-11 | 679 | 103 | 22 | 3.30.160.60 |
| Domain | zf-C2H2_6 | ZNF652 ZNF236 PRDM5 ZNF865 ZNF668 ZNF667 ZNF778 ZNF770 ZFP92 | 6.02e-05 | 314 | 103 | 9 | PF13912 |
| Domain | Anaphylatoxin_comp_syst | 2.98e-04 | 5 | 103 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.98e-04 | 5 | 103 | 2 | IPR001840 | |
| Domain | hEGF | 4.83e-04 | 28 | 103 | 3 | PF12661 | |
| Domain | ANATO | 6.21e-04 | 7 | 103 | 2 | SM00104 | |
| Domain | ANATO | 6.21e-04 | 7 | 103 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 6.21e-04 | 7 | 103 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.21e-04 | 7 | 103 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 6.21e-04 | 7 | 103 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 8.25e-04 | 8 | 103 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 8.25e-04 | 8 | 103 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 8.25e-04 | 8 | 103 | 2 | IPR019742 | |
| Domain | zf-C2H2_11 | 1.06e-03 | 9 | 103 | 2 | PF16622 | |
| Domain | A2M_N | 1.32e-03 | 10 | 103 | 2 | PF01835 | |
| Domain | A2M_N | 1.32e-03 | 10 | 103 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.32e-03 | 10 | 103 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.32e-03 | 10 | 103 | 2 | PS00477 | |
| Domain | A2M | 1.32e-03 | 10 | 103 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.32e-03 | 10 | 103 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.32e-03 | 10 | 103 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.32e-03 | 10 | 103 | 2 | PF07703 | |
| Domain | A2M_recep | 1.32e-03 | 10 | 103 | 2 | PF07677 | |
| Domain | A2M_comp | 1.32e-03 | 10 | 103 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.32e-03 | 10 | 103 | 2 | IPR001599 | |
| Domain | F-box-like | 1.83e-03 | 44 | 103 | 3 | PF12937 | |
| Domain | SET | 2.08e-03 | 46 | 103 | 3 | SM00317 | |
| Domain | zf-H2C2_2 | 2.62e-03 | 14 | 103 | 2 | PF13465 | |
| Domain | SET_dom | 2.65e-03 | 50 | 103 | 3 | IPR001214 | |
| Domain | SET | 2.65e-03 | 50 | 103 | 3 | PS50280 | |
| Domain | FBOX | 2.96e-03 | 52 | 103 | 3 | SM00256 | |
| Domain | C345C | 3.88e-03 | 17 | 103 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.35e-03 | 18 | 103 | 2 | IPR008930 | |
| Domain | NTR | 4.84e-03 | 19 | 103 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.84e-03 | 19 | 103 | 2 | IPR018933 | |
| Domain | F-box | 6.04e-03 | 67 | 103 | 3 | PF00646 | |
| Domain | LIM | 6.56e-03 | 69 | 103 | 3 | PF00412 | |
| Domain | - | 6.82e-03 | 70 | 103 | 3 | 2.10.110.10 | |
| Domain | zf-DHHC | 7.07e-03 | 23 | 103 | 2 | PF01529 | |
| Domain | NTR | 7.07e-03 | 23 | 103 | 2 | PS50189 | |
| Domain | Netrin_domain | 7.07e-03 | 23 | 103 | 2 | IPR001134 | |
| Domain | Znf_LIM | 7.10e-03 | 71 | 103 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 7.10e-03 | 71 | 103 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 7.10e-03 | 71 | 103 | 3 | PS50023 | |
| Domain | LIM | 7.10e-03 | 71 | 103 | 3 | SM00132 | |
| Domain | FBOX | 7.38e-03 | 72 | 103 | 3 | PS50181 | |
| Domain | C2H2_Znf_fam | 7.68e-03 | 24 | 103 | 2 | IPR027775 | |
| Domain | F-box_dom | 8.25e-03 | 75 | 103 | 3 | IPR001810 | |
| Domain | DHHC | 8.32e-03 | 25 | 103 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 8.32e-03 | 25 | 103 | 2 | IPR001594 | |
| Domain | TIMP-like_OB-fold | 8.98e-03 | 26 | 103 | 2 | IPR008993 | |
| Domain | EGF_3 | 9.76e-03 | 235 | 103 | 5 | PS50026 | |
| Domain | EGF | 9.76e-03 | 235 | 103 | 5 | SM00181 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK9 PHLDB3 PLOD3 SMG5 PTCH1 ZNF236 ZNF865 FBXO46 FANCA CDR2L MDN1 SUGP2 ZNF335 NFX1 CABIN1 MED13 ZNF687 | 4.78e-08 | 1105 | 107 | 17 | 35748872 |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 9.38e-06 | 2 | 107 | 2 | 16565498 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 9.38e-06 | 2 | 107 | 2 | 7373044 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 9.38e-06 | 2 | 107 | 2 | 1357031 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18794299 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 9.38e-06 | 2 | 107 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 9.38e-06 | 2 | 107 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 9.38e-06 | 2 | 107 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 9.38e-06 | 2 | 107 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 9.38e-06 | 2 | 107 | 2 | 15787745 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12207352 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30026462 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 9.38e-06 | 2 | 107 | 2 | 27758680 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 9.38e-06 | 2 | 107 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 9.38e-06 | 2 | 107 | 2 | 20506482 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30846936 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12480675 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 9.38e-06 | 2 | 107 | 2 | 23749435 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 9.38e-06 | 2 | 107 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 9.38e-06 | 2 | 107 | 2 | 3037333 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11726230 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 9.38e-06 | 2 | 107 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 9.38e-06 | 2 | 107 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 9.38e-06 | 2 | 107 | 2 | 2997024 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 9.38e-06 | 2 | 107 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 9.38e-06 | 2 | 107 | 2 | 8428773 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21857912 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24638111 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 9.38e-06 | 2 | 107 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 9.38e-06 | 2 | 107 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 9.38e-06 | 2 | 107 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 9.38e-06 | 2 | 107 | 2 | 3167981 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7545960 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30041577 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2572548 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 9.38e-06 | 2 | 107 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 9.38e-06 | 2 | 107 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 9.38e-06 | 2 | 107 | 2 | 18360261 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 9.38e-06 | 2 | 107 | 2 | 18091514 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 9.38e-06 | 2 | 107 | 2 | 26814963 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 9.38e-06 | 2 | 107 | 2 | 25339671 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17728371 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6149580 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6149581 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12115608 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3542363 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2387317 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8132550 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2395880 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26814708 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6192448 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6167582 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 9.38e-06 | 2 | 107 | 2 | 1438267 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7365238 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24376823 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19150565 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7391573 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17506029 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17971360 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23715124 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3464002 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 9.38e-06 | 2 | 107 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 9.38e-06 | 2 | 107 | 2 | 17971229 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 9.38e-06 | 2 | 107 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 9.38e-06 | 2 | 107 | 2 | 17921792 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 6978711 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35898513 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33353966 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3008092 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28873507 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 9.38e-06 | 2 | 107 | 2 | 2900855 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 6832377 | |
| Pubmed | Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease. | 9.38e-06 | 2 | 107 | 2 | 23077216 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 9.38e-06 | 2 | 107 | 2 | 17257223 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2272665 | ||
| Pubmed | Multiple C4/Slp genes distinguished by expression after transfection. | 9.38e-06 | 2 | 107 | 2 | 3023818 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22785613 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 32691186 | ||
| Interaction | ZFP28 interactions | 1.27e-06 | 37 | 104 | 5 | int:ZFP28 | |
| Interaction | ZFP37 interactions | 5.29e-06 | 49 | 104 | 5 | int:ZFP37 | |
| Interaction | ZNF667 interactions | 7.83e-06 | 53 | 104 | 5 | int:ZNF667 | |
| Interaction | ZNF287 interactions | 1.45e-05 | 60 | 104 | 5 | int:ZNF287 | |
| Interaction | ZNF710 interactions | 1.65e-05 | 30 | 104 | 4 | int:ZNF710 | |
| Interaction | GLIS1 interactions | 1.65e-05 | 30 | 104 | 4 | int:GLIS1 | |
| Interaction | ZNF697 interactions | 2.44e-05 | 33 | 104 | 4 | int:ZNF697 | |
| Interaction | SALL3 interactions | 2.75e-05 | 34 | 104 | 4 | int:SALL3 | |
| Interaction | ZNF652 interactions | 3.10e-05 | 35 | 104 | 4 | int:ZNF652 | |
| Interaction | ZSCAN21 interactions | 5.32e-05 | 128 | 104 | 6 | int:ZSCAN21 | |
| Interaction | CACNG5 interactions | 5.85e-05 | 41 | 104 | 4 | int:CACNG5 | |
| Interaction | EPC1 interactions | 6.24e-05 | 81 | 104 | 5 | int:EPC1 | |
| Interaction | CRIP3 interactions | 7.89e-05 | 3 | 104 | 2 | int:CRIP3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF717 KLF8 ZBTB6 ZNF652 SALL4 ZKSCAN2 ZNF223 ZNF275 ZNF236 PRDM5 ZNF865 KLF16 ZNF668 EGR4 ZNF451 ZNF335 GLIS2 ZNF667 PRDM12 ZNF778 ZNF770 ZFP92 ZNF319 PRDM6 | 4.41e-15 | 718 | 81 | 24 | 28 |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 5.63e-05 | 17 | 81 | 3 | 1197 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 6.73e-05 | 18 | 81 | 3 | 624 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.99e-04 | 9 | 81 | 2 | 1234 | |
| GeneFamily | LIM domain containing | 2.35e-03 | 59 | 81 | 3 | 1218 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.23e-07 | 194 | 106 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.37e-07 | 195 | 106 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.32e-06 | 170 | 106 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.92e-06 | 182 | 106 | 6 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 6.49e-06 | 191 | 106 | 6 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.69e-06 | 192 | 106 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.63e-05 | 78 | 106 | 4 | 83d308b15cb3c0820a27b95c8bc85afadf98370e | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.63e-05 | 78 | 106 | 4 | 387e7e07a5a509dc8415a7cb83a2c3940ca1ec85 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.97e-05 | 167 | 106 | 5 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 5.11e-05 | 168 | 106 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 171 | 106 | 5 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 172 | 106 | 5 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 172 | 106 | 5 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 176 | 106 | 5 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 6.90e-05 | 179 | 106 | 5 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 6.90e-05 | 179 | 106 | 5 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.27e-05 | 181 | 106 | 5 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.66e-05 | 183 | 106 | 5 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.27e-05 | 186 | 106 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.48e-05 | 187 | 106 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-05 | 187 | 106 | 5 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-05 | 187 | 106 | 5 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.48e-05 | 187 | 106 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.70e-05 | 188 | 106 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.14e-05 | 190 | 106 | 5 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.14e-05 | 190 | 106 | 5 | c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.14e-05 | 190 | 106 | 5 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.60e-05 | 192 | 106 | 5 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.60e-05 | 192 | 106 | 5 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.84e-05 | 193 | 106 | 5 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.84e-05 | 193 | 106 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.06e-04 | 196 | 106 | 5 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 197 | 106 | 5 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 197 | 106 | 5 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 197 | 106 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 1.11e-04 | 198 | 106 | 5 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 198 | 106 | 5 | c77421898cc84ae2e8cc335087198dd05f13bfa5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 106 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 106 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| Disease | Huntington's disease (implicated_via_orthology) | 1.69e-04 | 32 | 99 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | Constipation | 2.31e-04 | 7 | 99 | 2 | C0009806 | |
| Disease | Autistic behavior | 3.08e-04 | 8 | 99 | 2 | C0856975 | |
| Disease | X-21467 measurement | 3.95e-04 | 9 | 99 | 2 | EFO_0020007 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRLFSICRFVARSSK | 81 | Q9UK28 | |
| KLFRPTFCLAVACTD | 111 | Q75L30 | |
| SLPERRFFCSCQTLK | 216 | Q9NWW7 | |
| SRCCFSFAEQEIPLR | 31 | P22362 | |
| LKELCTSPRCKDAFR | 161 | Q86X02 | |
| CLFNRPTKLFEPTEC | 491 | O75077 | |
| FCGFLLCTNLTRAPR | 656 | O75077 | |
| DFLQRCLESPFSRKL | 236 | Q9NR81 | |
| PFLSCCQFAESLRKK | 731 | P0C0L5 | |
| LFLPRRSRCKFFSLT | 31 | Q8WTX7 | |
| RFSVVCNTKRLHCFP | 961 | Q8N139 | |
| SARLPCRLFFRVCLK | 51 | Q9NYJ7 | |
| FCTSCIKRNPEARLD | 181 | P56880 | |
| FGSCDKCFKQRALRP | 11 | O14775 | |
| TLCRKLRLPQAFDFC | 446 | O15381 | |
| CEECKALFRTPFSLQ | 406 | Q9NQX1 | |
| CRFLRYDCVISSPRK | 691 | O60568 | |
| LRCAFKSPNPRLTFC | 591 | Q6NSJ2 | |
| KRCFREFCIPTSSNI | 346 | P35372 | |
| CTNRTCLITFKPGAF | 211 | Q8NF37 | |
| LNRPIFSKCCFEVLT | 3061 | Q9NU22 | |
| RFSCPLCSKRFTRSD | 186 | Q9BXK1 | |
| LCKSIQTSCESFPLR | 366 | Q5T1H1 | |
| CVFSSSISFPCREQR | 331 | Q6W5P4 | |
| YTCKSLPRDERCNLT | 66 | Q8IV16 | |
| SFLPTRALAALKCTC | 486 | Q6PJ61 | |
| SFFCDLPRVTKLACL | 176 | Q8NGD3 | |
| ELAARSSRTNCPCKY | 211 | O76083 | |
| PTDSCSRLISLAKCF | 896 | Q9H7Z3 | |
| CRCSFRTKELPCTSL | 661 | Q12986 | |
| IKPFRCTDCNRSFSR | 331 | O95600 | |
| KRFFKCPCGNRSISL | 811 | Q7L590 | |
| KPFQCRICLRNFSRS | 511 | Q05215 | |
| TLDKPFVCRFCNRRF | 266 | Q9H4Q4 | |
| RCPTCSKSFSRLENL | 236 | Q9BZE0 | |
| LRVPSAARCCKAFST | 226 | Q8NGT2 | |
| TCAACKTPIRNRAFY | 366 | Q9NR12 | |
| PFKCERCERSFTQAT | 556 | Q9NQX0 | |
| ACVVKPDFSTCASRR | 106 | Q9NQ84 | |
| PGLACLRTSFNRFIC | 111 | Q9HC23 | |
| NKFAPRCARCSKTLT | 156 | Q13643 | |
| LSLFRPLCKFCVSVR | 166 | A1L0T0 | |
| QCIASFRLCLSRFPQ | 1511 | Q9Y6J0 | |
| CKPDSDRFVFLLCTR | 846 | Q8TD26 | |
| KQRSRSILSSFFCCF | 36 | O15194 | |
| FSFLPTNQLCRCARV | 126 | Q9UJT9 | |
| ERLFSVVAFKCPCST | 31 | Q8N5C1 | |
| LLTCRTRDSLFFCLK | 821 | O15360 | |
| NKSFRRAFLIILCCD | 316 | Q13639 | |
| CKCRPSKLFTSFSIL | 421 | Q8IZF7 | |
| TLCRDPKSFLYRLCQ | 61 | Q9NXV2 | |
| ERPYLCSICSKNFAR | 1021 | A0A0U1RQI7 | |
| FSFLDPRSLCRCAQV | 101 | Q8IX29 | |
| LIEICRTKASPYNRC | 81 | P50750 | |
| PDYTRKSCTILRCIS | 131 | Q0D2K5 | |
| ERPFQCKICGRAFST | 591 | Q9UJQ4 | |
| PFLSCCQFAESLRKK | 731 | P0C0L4 | |
| ACSLEEKLSLCFRPS | 51 | Q9UHY8 | |
| SRARFELLCSPLFNK | 296 | Q0VDF9 | |
| FTCPQCRKSFPRRSF | 181 | Q8WV44 | |
| IRTLDTPFRKNCSFS | 426 | Q99932 | |
| QTKRCFRLAPTFSNL | 576 | Q9UPR3 | |
| RRLDIFCCFTSPCVS | 606 | Q13635 | |
| LKSLAFSAFTQCRRP | 1711 | Q9UHV7 | |
| RLDTEKLCTFSQRFP | 36 | Q9P0N9 | |
| CRERVTFCHLPFQSK | 141 | Q5T5C0 | |
| CIKVSRPCTRLFSET | 1346 | Q8TER0 | |
| NPICYALCNRTFRKT | 491 | P08912 | |
| CKTLCTRQPFSLARE | 171 | Q9GZS9 | |
| FTCPQCRKSFTRRSF | 181 | Q96A61 | |
| PFECSNCRKAFRQIS | 171 | Q5HYK9 | |
| LFCRCSFDVPATKNS | 206 | Q8N2E2 | |
| ACPECGKLFRRSFAL | 181 | A6NM28 | |
| PNCFLLFSRKEECSK | 256 | Q9Y4E5 | |
| RCPFCRALFKAKSAL | 2631 | Q86UP3 | |
| ACSNRLCKLPSFISL | 901 | Q8IXZ2 | |
| KPFSCSVCSKSFNRR | 376 | P0CJ78 | |
| KPFICTVCRKSFRNS | 531 | Q96MU6 | |
| KPFKCEICSVSFRLR | 286 | Q9UK11 | |
| ERPFLCSECGKSFSR | 221 | Q96K58 | |
| KLKQCERCDRPFSIF | 411 | Q6ZMY6 | |
| SLDFRTFCTSCLIRK | 421 | Q8IUH4 | |
| TFCTSCLIRKPLRSL | 426 | Q8IUH4 | |
| YKFISCPTCRRETVL | 181 | Q9H0X6 | |
| KITCAPKTFCRNLFS | 406 | Q6IEE8 | |
| KINTRCLPFFSLDSR | 321 | Q9HCF6 | |
| LGECPRDNTCTRKFF | 521 | Q9NPD5 | |
| RFKCNTRLCLSITDF | 86 | Q8N2K1 | |
| RKKVFELCPSICFTS | 831 | Q8IX01 | |
| CFACRTRKTLFPNLV | 336 | Q9GZP7 | |
| PFICSSCKKTFVRLS | 576 | A6NDX5 | |
| RPFTCNECGKTFRLN | 631 | A6NDX5 | |
| KCLCRLLTNAPRTFS | 191 | Q99551 | |
| RLSRPLECSCFRTSI | 211 | Q5VZM2 | |
| SVRACLRTCFPSEAK | 1141 | Q00722 | |
| RPFKCVLCTKSFRQS | 186 | Q6IQ21 | |
| SIFCSTCLIRKPVRS | 436 | Q8IUH5 | |
| PFRCNECRKTFSQKS | 841 | Q9BY31 | |
| FNTLRGCERPLCKFA | 1101 | Q8N9V7 | |
| KPLRCTLCERRFFSS | 456 | Q9P2F9 | |
| FFQPRELSSKSKCFC | 216 | Q3LFD5 | |
| CGFLRTPEQCRTKFK | 541 | Q63HK3 | |
| KCPQCFRAFAVKSTL | 511 | Q9UL36 | |
| KKFPCRLCERSFCSA | 991 | Q8N1G0 | |
| CTFCLRPLTKGSFQE | 431 | O43294 | |
| FFQPRELSSKSKCFC | 216 | Q9UMW8 | |
| CQPFCKPRSSRLLTF | 446 | Q14139 | |
| FICEICGKSFTSRPN | 441 | Q9Y2D9 | |
| PFACKACSRDFLDRQ | 236 | Q9NSD4 | |
| DPQLFKCLQCSYRSR | 491 | Q9H4Z2 | |
| NPVSCDFVRKCFSSR | 166 | P0DJG4 | |
| IRPFQCTVCLKTFTA | 351 | Q15916 | |
| AKPCTSNCRINTFRT | 451 | O75113 | |
| RCCSPFTFLVNTKRQ | 66 | Q8NFW9 |